Omaha, NENCT06013865Now EnrollingIRB Ready

Kidney Transplant Clinical Trial in Omaha, NE

Access cutting-edge kidney transplant treatment through this phase 4 clinical trial at a research site in Omaha. Study-provided care at no cost to qualified participants.

Sponsored by VA Office of Research and Development

Quick Self-Assessment

See if you qualify for this Omaha location

Preparing your pre-screening questions…

Expert Care in Omaha

Access kidney transplant specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related kidney transplant treatment provided free

Apply for This Omaha Location

Check if you qualify for this kidney transplant clinical trial in Omaha, NE

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Omaha

    Convenient for NE residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Omaha site if eligible
  4. 4Begin participation

About This Kidney Transplant Study in Omaha

Kidney transplantation improves the health and quality of life for those Veterans with end stage kidney disease (ESKD). While early patient and graft survival are excellent, long-term outcomes continue to be challenging. Patient death with existing kidney graft function occurs in about half of all recipients over time. This is primarily due to the development of cardiovascular disease in a patient population with multiple preexisting cardiac disease risk factors. There has been little progress i

Sponsor: VA Office of Research and Development

Who Can Participate

Inclusion Criteria

Adult (\>18 years of age) male and female recipients (all races and ethnicities)
Subject must be able to understand and provide consent
Recipient of a primary or secondary kidney transplant at least 3 months or longer since transplant
For subjects with T2DM or post-transplant diabetes (PTDM), measured kidney function by CKD epi eGFR must be 30mL/min/1.73m2 to 59 mL/min/1.73m2 or CKD epi eGFR 60 mL/min/1.73m2 with urinary albumin:creatinine ratio 30 mg/g (or protein:creatinine 100 mg/g).
For subjects without T2DM or PTDM: measured kidney function by CKD epi eGFR must be 20mL/min/1.73m2 to 59mL/min/1.73m2 or CKD epi eGFR 60 mL/min/1.73m2 with urinary albumin:creatinine ratio 30 mg/g (or protein:creatinine 100 mg/g).

Exclusion Criteria

Inability or unwillingness of a participant to give written informed consent or comply with study protocol
History of prior pancreas transplant
CKD epi eGFR \< 30 mL/min/1.73m2 for those with T2DM or \< 20 mL/min/1.73m2 for those without T2DM or anyone with 5mL/min/1.73m2 fall in eGFR per year
Uncontrolled type 2 diabetes mellitus with most recent A1C\>12%
History of \>2 urinary tract infections per year or UTIs requiring admission in the last year, or urosepsis in the last year.
Use of SGLT2i within 90 days
Documented allergy to SGLT2i
History of Type I diabetes mellitus
History of diabetic ketoacidosis
Indwelling foley catheter or urinary diversion
Acute rejection in the prior 3 months
Acute MACE event within 3 months of the study
Severe congestive heart failure (NYHA functional class III or higher)
Active mucocutaneous mycotic infection of the groin or external genitalia.
History of amputation due to peripheral vascular disease and/or diabetic foot ulcers within prior year
History of malignancy except non-melanoma skin cancer within 2 years of screening
Known of active current viral, fungal, mycobacterial, or other infections (including, but not limited to tuberculosis and atypical mycobacterial disease)
HIV infected subjects, including those who are well controlled on anti-retrovirals
Recent (within 6 months) Positive Hep B PCR or active disease
Hepatitis C virus antibody positive (HCVAb+) subjects who have failed to demonstrate sustained viral remission for more than 12 weeks (after anti-viral treatment)
Active pregnancy in a female transplant recipient
A condition, in the eyes of the investigator, that precludes inclusion into the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Omaha?

Yes, this clinical trial (NCT06013865) has an active research site in Omaha, NE that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Kidney Transplant Treatment Options in Omaha, NE

If you're searching for kidney transplant treatment options in Omaha, NE, this clinical trial (NCT06013865) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Omaha research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced kidney transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all kidney transplant clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Omaha, NE

See all rheumatoid arthritis clinical trials recruiting in Omaha — not just this study.

Browse Rheumatoid Arthritis Trials in Omaha →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAll Conditions →

Ready to Join in Omaha?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Omaha, NE